Emerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3
- 31 July 2010
- journal article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 121 (1-2), 130-135
- https://doi.org/10.1016/j.jsbmb.2010.02.036
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormoneThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Multifunctional Enhancers Regulate Mouse and Human Vitamin D Receptor Gene TranscriptionMolecular Endocrinology, 2010
- ChIP-Seq of ERα and RNA polymerase II defines genes differentially responding to ligandsThe EMBO Journal, 2009
- PPARγ and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scaleGenes & Development, 2008
- Targeted Deletion of a Distant Transcriptional Enhancer of the Receptor Activator of Nuclear Factor-κB Ligand Gene Reduces Bone Remodeling and Increases Bone MassEndocrinology, 2007
- Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptorThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Genome-wide analysis of estrogen receptor binding sitesNature Genetics, 2006
- Parathyroid Hormone Controls Receptor Activator of NF-κB Ligand Gene Expression via a Distant Transcriptional EnhancerMolecular and Cellular Biology, 2006
- Activation of Receptor Activator of NF-κB Ligand Gene Expression by 1,25-Dihydroxyvitamin D3 Is Mediated through Multiple Long-Range EnhancersMolecular and Cellular Biology, 2006
- Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target PromoterCell, 2003